gm-xantho
Botanicalexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2020 (NCT04369846)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06620692 | Phase 2 | Oct 1, 2025 | Virginia Contract Research Organization Co., Ltd., Xantho Biotechnology Co., LTD |
| NCT05199077 | Phase 2 | Jul 1, 2022 | Virginia Contract Research Organization Co., Ltd., Xantho Biotechnology Co., LTD |
| NCT04369846 | Phase 1/Phase 2 (Phase 2) | May 1, 2020 | Xantho Biotechnology Co., LTD |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Xantho Biotechnology Co., LTD | For profit | 3 | 3 | 1 | 2020 |
| Virginia Contract Research Organization Co., Ltd. | For profit | 2 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1